Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

Growth Hormone and IGF Research

Volumn 19, Issue 6, 2009, Pages 471-477

  Sackmann Sala, Lucila ^a   Ding, Juan ^a   Frohman, Lawrence A ^b   Kopchick, John J ^a  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Albumin; Apolipoprotein A1; Biomarkers; GHRH analog; Growth hormone; Hemoglobin; IGF 1; Serum proteomics; Transthyretin

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; CJC 1295; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HEMOGLOBIN BETA CHAIN; IMMUNOGLOBULIN HEAVY CHAIN; PREALBUMIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; SINGLE DRUG DOSE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; INSULIN-LIKE GROWTH FACTOR I; MALE; MASS SPECTROMETRY; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; PITUITARY GLAND; PROTEOMICS; RECOMBINANT PROTEINS;

EID: 72049129696     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.03.001     Document Type: Article

References (27)

1. American Association of Clinical Endocrinologists Growth Hormone Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children - 2003 update. Endocr. Pract. 9 (2003) 64-76
2. Zhan X., Giorgianni F., and Desiderio D.M. Proteomics analysis of growth hormone isoforms in the human pituitary. Proteomics 5 (2005) 1228-1241
3. Nelson A.E., and Ho K.K. A robust test for growth hormone doping - present status and future prospects. Asian J. Androl. 10 (2008) 416-425
4. Erotokritou-Mulligan I., Bassett E.E., Bartlett C., et al. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J. Clin. Endocrinol. Metab. 93 (2008) 2760-2763
5. Holt R.I., and Sonksen P.H. Growth hormone, IGF-I and insulin and their abuse in sport. Br. J. Pharmacol. 154 (2008) 542-556
6. Powrie J.K., Bassett E.E., Rosen T., et al. Detection of growth hormone abuse in sport. Growth Horm. IGF Res. 17 (2007) 220-226
7. Bidlingmaier M., Wu Z., and Strasburger C.J. Problems with GH doping in sports. J. Endocrinol. Invest. 26 (2003) 924-931
8. Ionescu M., and Frohman L.A. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J. Clin. Endocrinol. Metab. 91 (2006) 4792-4797
9. Teichman S.L., Neale A., Lawrence B., Gagnon C., Castaigne J.P., and Frohman L.A. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J. Clin. Endocrinol. Metab. 91 (2006) 799-805
10. List E.O., Berryman D.E., Palmer A.J., et al. Analysis of mouse skin reveals proteins that are altered in a diet-induced diabetic state: a new method for detection of type 2 diabetes. Proteomics 7 (2007) 1140-1149
11. Qiu L., List E.O., and Kopchick J.J. Differentially expressed proteins in the pancreas of diet-induced diabetic mice. Mol. Cell Proteomics 4 (2005) 1311-1318
12. Kopchick J.J., List E.O., Kohn D.T., Keidan G.M., Qiu L., and Okada S. Perspective: proteomics - see "spots" run. Endocrinology 143 (2002) 1990-1994
13. Mascot. http://www.matrixscience.com.
14. MS-Seeker. http://www.msseeker.org.
15. Sheskin D.J. Handbook of Parametric and Nonparametric Statistical Procedures (1997), CRC Press, Boca Raton, FL p. 719
16. UniProt Consortium. The Universal Protein Resource (UniProt) 2009. Nucleic Acids Res. 37 (2009) D169-D174
17. Hoogland C., Mostaguir K., Sanchez J.C., Hochstrasser D.F., and Appel R.D. SWISS-2DPAGE, ten years later. Proteomics 4 (2004) 2352-2356
18. Lanes R., Soros A., Gunczler P., et al. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins. J. Pediatr. 149 (2006) 324-329
19. Schaefer G.B., Greger N.G., Fesmire J.D., Blackett P.R., Wilson D.P., and Frindik J.P. Lipids and apolipoproteins in growth hormone-deficient children during treatment. Metabolism 43 (1994) 1457-1461
20. Blackett P.R., Weech P.K., McConathy W.J., and Fesmire J.D. Growth hormone in the regulation of hyperlipidemia. Metabolism 31 (1982) 117-120
21. Parkinson C., Drake W.M., Wieringa G., Yates A.P., Besser G.M., and Trainer P.J. Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly. Clin. Endocrinol. (Oxford) 56 (2002) 303-311
22. Oscarsson J., Wiklund O., Jakobsson K.E., Petruson B., and Bengtsson B.A. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy. Clin. Endocrinol. (Oxford) 41 (1994) 603-608
23. Wang M., Chen M., Zheng G., et al. Transcriptional activation by growth hormone of HNF-6-regulated hepatic genes, a potential mechanism for improved liver repair during biliary injury in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295 (2008) G357-G366
24. Kelley K.W., Weigent D.A., and Kooijman R. Protein hormones and immunity. Brain Behav. Immun. 21 (2007) 384-392
25. Lahuna O., Fernandez L., Karlsson H., et al. Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone. Proc. Natl. Acad. Sci. USA 94 (1997) 12309-12313
26. Samadani U., and Costa R.H. The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression. Mol. Cell Biol. 16 (1996) 6273-6284
27. Chung L., Clifford D., Buckley M., and Baxter R.C. Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry. J. Clin. Endocrinol. Metab. 91 (2006) 671-677